Morphological Changes of Benign Prostatic Hyperplasia in Culture

Comparison of Matrix Metalloproteinases 2 mRNA Expression in Prostatic Adenocarcinoma and Benign Prostatic Hyperplasia

Background and Aims: Prostate cancer is the second most common cancer in men worldwide in men. Matrix metalloproteinase 2 (MMP2) has a role in the invasion and destruction of the basement membrane and the extra-cellular matrix and facilitating the process of tumor cell invasion. The present study was conducted to compare the expression of MMP2 gene in prostate cancer (PCa) and benign prostatic ...

Benign prostatic hyperplasia.

This article reviews the epidemiology of benign prostatic hyperplasia (BPH), evaluation of patients with lower urinary tract symptomatology (LUTS), and management of patients with BPH and LUTS. The evaluation includes history and physical examination, laboratory testing, and specialized studies. The management includes medical and surgical options. Medical options include alpha-1-adrenergic rec...

Benign Prostatic Hyperplasia

Urinary obstruction as a result of benign prostatic disease has probably been recognized to some degree since the earl iest days of medicine. This association was probably f irst formalized by Riolan in the seventeenth century. In the mideighteenth century, Morgagni (248) provided one of the earl iest descriptions of BPH and enumerated many of the potential medical problems attendant to its dev...

Benign Prostatic Hyperplasia (bph)

Comprehensive studies show that the holmium laser is ideal for treating BPH. Holmium laser treatments have been the most rigorously investigated BPH techniques. Over 90 articles have been published from 8 randomized clinical trials and over 30 case studies and comparative series. The American, European, British and Australasian urology associations recommend holmium laser for BPH treatment. Hol...

Benign prostatic hyperplasia.